Gritstone bio supports mRNA Covid-19 vaccine plans with Phase I publication

Gritstone bio has reported interim results from an ongoing Phase 1 study evaluating the company’s self-amplifying mRNA (samRNA) vaccine as a boost against Covid-19 (CORAL-BOOST).